Steve Brine: The National Institute for Health and Care Excellence (NICE) has recently published interventional procedures guidance on a number of new procedures and is currently developing guidance on another, all for use in the treatment of glaucoma. NICE interventional procedures guidance makes recommendations for the National Health Service on whether new operational procedures are sufficiently safe...
Steve Brine: NHS England has advised that it does not hold this information.
Steve Brine: Inflammatory Bowel Disease is the collective name used to describe ulcerative colitis and Crohn’s disease. To support commissioners and clinicians to deliver evidence based local services for people with Crohn’s disease and ulcerative colitis, the National Institute for Health and Care Excellence (NICE) published the best practice guidance, ‘Crohn’s Disease Management in Adults,...
Steve Brine: This information is not collected. The National Institute for Health and Care Excellence guideline ‘Crohn’s Disease Management in Adults, Children and Young People’ states that there are currently at least 115,000 people in the United Kingdom with Crohn's disease. The full guideline, which was updated in 2016, can be found at the following link:...
Steve Brine: The Government’s commitment to funding cancer research has not changed because of the referendum. Rare and paediatric cancer research, along with all cancer research, is a strong priority for the Government including through the National Institute for Health Research, which has invested £745 million in cancer research from 2010/11 to 2015/16. My Rt. hon. Friend the Prime Minister has...
Steve Brine: As with all public services, local National Health Service areas are obliged to live within their agreed budget – otherwise they effectively take up resources that could be spent on general practitoners, mental health care, and cancer treatment. However, it is for local leaders in sustainability and transformation partnership areas, working together with NHS England and NHS Improvement, to...
Steve Brine: Dr Andrew Davies has the support of very experienced senior management teams, for both NHS Halton Clinical Commissioning Group (CCG) and NHS Warrington CCG. Dr Davies will undertake his role and accountabilities, attending committees and governing bodies for both CCGs. The joint senior management team meets weekly (every Monday) with Dr Davies attending and chairing each weekly meeting for...
Steve Brine: NHS England has advised that the appointment of the Chief Officer is made by the leadership team of the Clinical Commissioning Group. Accountable Officer status is then confirmed by Simon Stevens, Chief Executive (and Accounting Officer) of NHS England.
Steve Brine: NHS England confirms that no bonuses have been paid.
Steve Brine: NHS England does not hold this information. NHS England does not support bonus payments to general practitioners for reducing referrals.
Steve Brine: The Department has regular and ongoing dialogue with NHS England and the National Institute for Health and Care Excellence on matters related to medicines pricing and patient access to new treatments. We will consider all relevant issues in upcoming discussions with the pharmaceutical industry on medicines pricing arrangements for 2019 onwards to succeed the current Pharmaceutical Price...
Steve Brine: Reconstructive or plastic surgery can be available on the National Health Service. This is different from cosmetic surgery; it is surgery to restore a person's normal appearance after illness, accident or a birth defect. It includes procedures such as rebuilding breasts after a mastectomy, or repairing a cleft lip.
Steve Brine: Public Health England is working on providing updated estimates of hepatitis C (HCV) prevalence and disease burden at the sub-national level, covering the 22 Operational Delivery Network (ODN) areas that deliver HCV treatments in England. The new ODN HCV profile tool will make use of a broad range of HCV indicator data, including: surveillance data on HCV prevalence in people who inject...
Steve Brine: The figure for the number of lives saved over three years is the difference between two figures: - the number of deaths from cancer occurring in one year, taking into account the last published set of survival rates (these were for patients followed up until 2015, at the time of writing of the March 2017 report) and the number of new cancer cases each year (there were approximately 297,000...
Steve Brine: At the time of writing of the March 2017 report the figures for survival rates for patients followed up until 2016 and until 2017 had to be estimated. Estimates took into account the existing data on the number of new cases (approximately 297,000 in 2014) and assumed that survival rates would continue to increase at rates approximately similar to the ones revealed in the latest data. With...
Steve Brine: The Department does not hold up to date information on the number of Public Access Defibrillators. Whilst St Helens Clinical Commissioning Group (CCG) does not commission defibrillators for use in public areas, it has confirmed that many, if not all, general practitioner practices will have defibrillators in-house. However, the CCG does not buy or maintain these on behalf of practices. The...
Steve Brine: NHS England has responsibility for cardiovascular disease (CVD) services, and works with the Resuscitation Council (UK) (RCUK), the British Heart Foundation (BHF) and others to look at ways to promote and improve cardiopulmonary resuscitation (CPR) training and the availability of Public Access Defibrillators (PADs). Since the CVD Outcomes Strategy was published in 2013, which highlighted...
Steve Brine: NHS England has responsibility for cardiovascular disease (CVD) services, and works with the Resuscitation Council (UK), the British Heart Foundation (BHF) and others to look at ways to promote and improve cardiopulmonary resuscitation (CPR) training and the availability of Public Access Defibrillators (PADs). Since the CVD Outcomes Strategy was published in 2013, which highlighted the...
Steve Brine: Since April 2017, there are currently 27 drugs in 42 indications that are funded by the Cancer Drugs Fund (CDF). A full list of current and previous CDF drugs can be viewed at the following link: https://www.england.nhs.uk/cancer/cdf/cancer-drugs-fund-list / The latest published spend for the first six months of 2017/18 implies a circa £76 million of unused funding for that period...
Steve Brine: This information is not held centrally. NHS England is currently developing plans for national data collection.